Overview

Prospective L-arginine Study

Status:
Terminated
Trial end date:
2015-07-01
Target enrollment:
Participant gender:
Summary
HYPOTHESIS The investigators primary hypothesis is that peripheral endothelial function and exercise tolerance will be abnormal in the population of young heart transplant patients at baseline, and that each will show a trend towards improvement following a 12 week course of oral L-arginine, with regression towards the baseline following the 12 week washout period.
Phase:
Phase 1
Details
Lead Sponsor:
University of Michigan